
Figure 1
Representative DVH-s for multicatheter interstitial brachytherapy (MIBT) (solid line) and CyberKnife (CK) treatment (dashed line) for accelerated partial breast irradiation. The prescribed dose was 25 Gy. The target volume is indicated with red, the non-target breast with yellow, the ipsilateral lung with blue and the heart with orange. The solid red line clearly shows that with MIBT volumes irradiated by high doses (> 25 Gy) develop within the target volume.
Table 1
Tumour localization according to breast quadrants in patients treated by multicatheter interstitial brachytherapy (MIBT) and CyberKnife (CK)
| Method of treatment | Laterality | Upper outer | Lower outer | Upper inner | Lower inner | Central |
|---|---|---|---|---|---|---|
| MIBT | right | 3 | 1 | 3 | 2 | 4 |
| left | 3 | 3 | 4 | 1 | 8 | |
| CK | right | 6 | 6 | 2 | 1 | 2 |
| left | 2 | 4 | 1 | 3 | 5 |
Table 2
Absolute volumes of the body irradiated by 100%, 50% and 20% of the prescribed dose for multicatheter interstitial brachytherapy (MIBT) and CyberKnife (CK) treatments
| Body | MIBT | CK | p-value* |
|---|---|---|---|
| V100 (cm3) | 66.4 (28.9−193.8) | 77.1 (18.3−141.5) | 0.0356 |
| V50 (cm3) | 159.0 (73.4−444.2) | 189.3 (58.6−397.6) | 0.0184 |
| V20 (cm3) | 470.7 (253.4−1078.1) | 609.1 (326.7−1160.8) | 0.0013 |
Table 3
Dosimetry of ipsilateral breast for multicatheter interstitial brachytherapy (MIBT) and CyberKnife (CK) treatments. The values are given in percentages
| MIBT | CK | p-value* | |
|---|---|---|---|
| Whole breast | |||
| V100 | 9.7 (2.2−29.7) | 9.6 (0.9−20.4) | 0.9381 |
| V50 | 23.2 (5.1−68.0) | 23.3 (2.7−47.1) | 0.9822 |
| Non-target breast | |||
| V100 | 1.6 (0.4−4.2) | 0.7 (0.0−2.0) | < 0.0001 |
| V90 | 2.8 (0.6−8.1) | 2.3 (0.0−4.4) | 0.7019 |
| V50 | 12.9 (3.1−35.4) | 10.5 (1.7−18.9) | 0.5501 |
| V25 | 31.8 (9.4−68.4) | 29.9 (7.6−55.2) | 0.8772 |
Table 4
Dosimetry of ipsilateral lung for multicatheter interstitial brachytherapy (MIBT) and CyberKnife (CK) treatments. The values are given in percentages
| Ipsilateral lung | MIBT | CK | p-value* |
|---|---|---|---|
| Mean lung dose | 4.9 (1.9−11.1) | 4.9 (1.6−11.8) | 0.9946 |
| D0.1cm3 | 41.0 (10.1−61.5) | 52.2 (15.6−90.5) | 0.0068 |
| D1cm3 | 36.1 (8.7−55.8) | 45.4 (14.4−84.5) | 0.0162 |
| D2cm3 | 33.6 (8−52.5) | 42.2 (13.7−80.5) | 0.0198 |
| D2 | 21.2 (7.4−32.9) | 24 (8.8−46.4) | 0.2454 |
| V5 | 30.6 (5.1−50.0) | 30.7 (5.8−63.2) | 0.9357 |
Table 5
Dosimetry of heart for multicatheter interstitial brachytherapy (MIBT) and CyberKnife (CK) treatments. The values are given in percentages
| Heart | MIBT | CK | p-value* |
|---|---|---|---|
| Mean heart dose | 4.1 (1.0−7.7) | 3.3 (1.3−6.9) | 0.1706 |
| D0.1cm3 | 21.4 (4.0−47.2) | 18.9 (8.4−43.2) | 0.2822 |
| D1cm3 | 18.2 (3.2−42.3) | 16.6 (7.3−40.3) | 0.4878 |
| D2cm3 | 17 (3.0−40.0) | 15.6 (6.8−38.3) | 0.5324 |
| D2 | 13.3 (4.3−26.4) | 12.5 (5.2−31.5) | 0.5098 |
| V5 | 29.9 (0.0−62.5) | 21.2 (6.1−41.0) | 0.1653 |
Table 6
Dosimetry of skin and ribs for multicatheter interstitial brachytherapy (MIBT) and CyberKnife (CK) treatments. The values are given in percentages except for V100 and V50
| Skin | MIBT | CK | p-value* |
|---|---|---|---|
| D0.1cm3 | 75.3 (18.0−164.2) | 88.8 (27.6−112.4) | 0.0080 |
| D0.2cm3 | 70.3 (17.4−140.7) | 86.8 (21.1−111.1) | 0.0053 |
| D1cm3 | 58.4 (15.0−97.1) | 79 (22.8−106.0) | 0.0007 |
| Ribs | |||
| D0.1cm3 | 53.7 (8.1−92.7) | 78.9 (17.6−108.4) | 0.0003 |
| D1cm3 | 43.1 (5.3−76.4) | 69.1 (16.4−105) | 0.0004 |
| V100 (cm3) | 0 (0−0) | 0.2 (0.0−3.0) | 0.0101 |
| V50 (cm3) | 2 (0.0−16.4) | 4.2 (0.0−13.4) | 0.0105 |
Table 7
Dosimetry of contralateral breast and lung for multicatheter interstitial brachytherapy (MIBT) and CyberKnife (CK) treatments. The values are given in percentages
| Contralateral breast | MIBT | CK | p-value* |
|---|---|---|---|
| D0.1cm3 | 4 (0.0−9.8) | 2.1 (0.3−11.2) | 0.0039 |
| D1cm3 | 2.6 (0.0−6.4) | 1.8 (0.3−9.9) | 0.0378 |
| Contralateral lung | |||
| D0.1cm3 | 5.5 (0.0−11.7) | 3 (1.0−5.6) | 0.0000 |
| D1cm3 | 3.6 (0.0−8.3) | 2.5 (0.6−4.8) | 0.0228 |

Figure 2
Representative dose distribution for multicatheter interstitial brachytherapy (MIBT) (A) and CyberKnife (CK) treatment (B). PTV: red, ipsilateral breast: yellow, contralateral breast: pink, ribs: green, heart: orange, ipsilateral lung: dark blue, contralateral lung: light blue.
Table 8
Treatment characteristics and mean dosimetric parameters in publications for accelerated partial breast irradiation (APBI) with CyberKnife
| Publication | Xu 201225 | Vermeulen 201451 | Goggin 201526 | Rault 201627 | Obayomi 201652 | Lozza 201853 | Bonfantini 201828 | Lee 201829 | Lee 202054 | Fröhlich 202036 | Current study |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient number | 14 | 21 | 9 | 10 | 10 | 20 | 10 | 10 | 103 | 25 | 32 |
| Applicator | Cones | - | Iris, MLC | Iris | - | Iris | Iris | Cones | - | MLC | MLC |
| Beam number | - | 151 | - , - | - | 155 | 180 | 122 | - | - | - | 40 (57)@ |
| Fractionation | 10 x 3.85 Gy | 10 x 3.4 Gy | 5 x 6 Gy | 10 x 4 Gy | 5 x 6 Gy | 6 5 Gy x | 5 x 6 Gy | 5 x 6 Gy | 5 x 6 Gy | 4 x 6.25 Gy | 4 x 6.25 Gy |
| Treatment Time (min) | - | 46 | 28, 14.7 | 40 | - | 60 | 60 | 60 | 33# | - | 33.3 |
| CTV-PTV margin (mm) | 2 | 2 | 2 | 3 | 5 | 5 | 5 | 2 | 0 | 2 | 2 |
| Mean PTV volume (cm3) | - | 114 | - | - | 70 | 88.1 | 121.6 | 37.7 | 73.6 | 71.6 | 71.7 |
| Ipsilateral breast | |||||||||||
| V100 (%) | 7# | 12 | 12.5, 12.2 | 14 | 28.7 | 10 | - | 9.6 | |||
| V50 (%) | 22.4# | 26 | 25.8, 24.2 | 31 | 75 | 24 | 35.5# | 23.3 | |||
| Ipsilateral non-target breast | |||||||||||
| V100 (%) | 9 | - | 1.7 | - | 0.7 | ||||||
| V50 (%) | 23.1 | 17.6 | 16.3 | - | 10.5 | 10.5 | |||||
| Ipsilateral lung | |||||||||||
| V30 (%) | 1.3 | 1.9, 1.6 | 2.3 | 2.1 | 2.2# | 1.0 | |||||
| V5 (%) | 31.4# | 39.4, 17.9 | 30.7 | ||||||||
| mean dose (%) | 4.9 | ||||||||||
| D0.1cm3 | 57.5 | 52.2 | |||||||||
| D1cm3 | 45 | 45.4 | |||||||||
| Heart | |||||||||||
| V5 (%) | 9.4 | 10 | 3.9 | 31 | 14 | 23.2 | 23 | - | 21.2 | ||
| mean dose (%) | 2.3# | 3.3 | |||||||||
| D0.1cm3 | 12.1 | 18.9 | |||||||||
| D1cm3 | 10.5 | 16.6 | |||||||||
| Skin | |||||||||||
| Dmax (%) | - | 108.8 | - | - | 106.6 | 98.2 | 94.7 | 103.3 | 88.7# | 99.6* | 88.8* |
| Contralateral breast | |||||||||||
| Dmax (%) | 1.6 | 3 | - | - | 10 | - | - | 10 | 2.7# | 3.8* | 2.1* |